Abstract
PURPOSE: COPD patients with impaired QOL are more likely to experience exacerbations and thereby utilize more healthcare resources. The objective of the present analysis was to quantify the impact of cilomilast, a selective phosphodiesterase 4 inhibitor, on QOL in patients with higher St. George's Respiratory Questionnaire (SGRQ) scores at baseline (higher SGRQ score is indicative of greater impairment in QOL).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.